Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States

CONCLUSION: Cumulative mean OOP costs among commercially insured patients during the 3-year period post-cancer diagnosis were substantial and generally higher among those with later stage cancer diagnoses. Diagnosis of cancer at earlier stages may allow for more timely treatment and lessen patient OOP costs.PMID:37907436 | DOI:10.1080/13696998.2023.2254649

Source: Journal of Medical Economics - November 1, 2023 Category: Health Management Authors: November McGarvey Matthew Gitlin Ela Fadli Karen C Chung Source Type: research